Organ uptake (SUVmean) and background contribution of blood activity to BM uptake in patients at 45-mg cold dose of daratumumab
| Organs . | MM patients (patient 7, patient 8) . | Solitary plasmacytoma patient (patient 9) . | ||
|---|---|---|---|---|
| Day 1 . | Day 2 . | Day 1 . | Day 2 . | |
| Lumbar vertebrae | 34.8 ± 9.6 | 33.9 ± 11.0 | 7.4 ± 1.6 | 8.4 ± 2.2 |
| Liver | 5.7 ± 2.6 | 6.0 ± 2.5 | 6.8 ± 1.1 | 7.1 ± 1.6 |
| Spleen | 9.3 ± 4.1 | 8.4 ± 3.6 | 9.8 ± 1.6 | 9.0 ± 1.9 |
| Blood (heart) | 0.9 ± 0.3 | 0.8 ± 0.4 | 4.6 ± 0.8 | 2.7 ± 0.8 |
| Blood activity contribution to BM, % | 1.0 ± 0.4 | 0.9 ± 0.5 | 22.5 ± 7.3 | 11.5 ± 5.1 |
| Organs . | MM patients (patient 7, patient 8) . | Solitary plasmacytoma patient (patient 9) . | ||
|---|---|---|---|---|
| Day 1 . | Day 2 . | Day 1 . | Day 2 . | |
| Lumbar vertebrae | 34.8 ± 9.6 | 33.9 ± 11.0 | 7.4 ± 1.6 | 8.4 ± 2.2 |
| Liver | 5.7 ± 2.6 | 6.0 ± 2.5 | 6.8 ± 1.1 | 7.1 ± 1.6 |
| Spleen | 9.3 ± 4.1 | 8.4 ± 3.6 | 9.8 ± 1.6 | 9.0 ± 1.9 |
| Blood (heart) | 0.9 ± 0.3 | 0.8 ± 0.4 | 4.6 ± 0.8 | 2.7 ± 0.8 |
| Blood activity contribution to BM, % | 1.0 ± 0.4 | 0.9 ± 0.5 | 22.5 ± 7.3 | 11.5 ± 5.1 |